Robert A. Michael is VP & Controller at AbbVie Inc. (ABBV). They have made 6 open-market trades across 1 company since 2017, most recently 2026-02-27.
CIK 0001699914
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABBV | 178,737 | $51.0M |
Shares reported on the most recent Form 4, priced at the 2026-03-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABBV | SELL | 2024-02-29 | 2024-03-01 | $176.45 | $24.3M | +0.8% | +1.4% | -12.4% |
| ABBV | SELL | 2022-03-01 | 2022-03-01 | $148.25 | $12.8M | +0.9% | +9.8% | -0.2% |
| ABBV | SELL | 2018-02-28 | 2018-03-02 | $119.43 | $1.0M | +4.4% | -19.7% | -13.1% |
| ABBV | SELL | 2018-02-20 | 2018-02-20 | $120.32 | $191K | -2.9% | -17.2% | -10.4% |
| ABBV | SELL | 2017-09-28 | 2017-09-29 | $88.00 | $590K | +2.9% | +1.4% | +9.0% |
| ABBV | SELL | 2017-03-10 | 2017-03-10 | $65.29 | $670K | -0.5% | -1.4% | +4.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.